Project Details
Description (abstract)
This is a randomized controlled multicenter study that focuses on severe CRSwNP ± asthma ±AERD. The clinical significance of this study is to develop cost-effective treatment models that will facilitate risk-estimation and prevention of the onset and the progression of severe CRSwNP, asthma and AERD.
Acronym | AirGOs-Oper, AirGOs-Medical |
---|---|
Status | Active |
Effective start/end date | 01/05/2018 → … |